Latest Business Development News

4DS Memory Limited has successfully manufactured its first 20nm memory cell array, marking a pivotal step in its ReRAM technology development, while raising $8.6 million through a placement and Share Purchase Plan to fuel ongoing innovation.

Australian Bond Exchange Holdings (ASX: ABE) reported a strong $3.6 billion trading volume for Q3 FY25 and announced a strategic partnership with ViewTrade Australia, while securing $1.8 million in funding to support its growth trajectory.

Ronin Resources has made significant strides in its La Punilla gold-silver project in Argentina, while navigating socio-political hurdles in Colombia and refining its lithium exploration efforts in Canada. The company maintains a solid cash position as it pursues new business opportunities.

Patrys Limited advances its PAT-DX3 therapy development for inflammatory diseases while navigating cash flow challenges and pursuing partnerships to sustain operations.

Cosmo Metals has completed the acquisition of the Bingara and Nundle gold-antimony-copper projects in NSW and progressed exploration at its Kanowna Gold Project in WA, supported by a $1.1 million capital raise.

PainChek Limited reports strong progress toward FDA De Novo clearance for US market entry, launches its Infant App in Australia, and achieves robust global licence growth with a 30% year-on-year revenue increase.

Island Pharmaceuticals has completed dosing in the Phase 2b cohort of its dengue fever trial, with pharmacokinetic targets met and top-line results expected next month. The company also strengthened its balance sheet by raising $1.94 million through option exercises.

Peako Limited reports a quiet quarter in East Kimberley exploration due to seasonal conditions but successfully completes a significant capital raise, bolstering its cash position to nearly A$2 million.

Careteq Limited reports strong Q3 FY25 progress with near completion of its 1-System platform integration, revenue growth exceeding forecasts, and new strategic partnerships broadening its healthcare footprint.

Stelar Metals advances its exploration and business development efforts in Tier 1 Australian jurisdictions, spotlighting the promising Baratta Copper Project in South Australia.

Vitrafy Life Sciences reported strong Q3 FY2025 progress, including a successful US Army blood platelet study, a $4.8 million government grant, and strategic US market expansion.

SG Fleet Group reported robust first-half 2025 results, driven by strong delivery volumes and revenue growth across Australia, New Zealand, and the UK, despite ongoing pressures in the used vehicle market.